Screener / SEC EDGAR /CIK 0001635088 /10-K filed May 20, 2026, compared with May 29, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Pharmaceuticals

Roivant Sciences Ltd. ROIV

Compare with peers Embed
Insider trades since May 20, 2026

8 insiders sold $304.4M on the market, none bought

Form 4
Bought on the market $0 0 trades
Sold on the market $304.4M 52 trades by 8 insiders
Sold under a 10b5-1 plan 22% of the value sold, under a plan set up in advance
Traded the most Mayukh Sukhatme $70.6M President & CIO

Open-market buys and sales are the trades an insider chose to make. Grants, option exercises and shares withheld for tax are pay; they show under All.

A year of insider trades, day by day

Open-market buys and sales by officers and directors · Form 4, since Nov 24, 2025

NovDecJanFebMarAprMayJunJulAugSepOctNov Mon Wed Fri

$0 bought on 0 days, $304.4M sold on 23 days. Each square is a day; click one for its Form 4.

SoldBought

Buys and sales by insider

Who traded · Form 4, added up

InsiderBoughtSoldLatest
Mayukh Sukhatme
President & CIO, Director
-$70.6M Aug 21, 2026
Eric Venker
President & Immunovant CEO
-$63.4M Nov 10, 2026
Keith S. Manchester
Director
-$56.4M Jun 30, 2026
QVT Financial LP
-$49.4M Jun 30, 2026
Daniel Allen Gold
Director
-$49.4M Jun 30, 2026
Richard Pulik
CFO
-$12.5M Nov 11, 2026
Melissa B. Epperly
Director
-$1.4M Oct 1, 2026
Meghan Fitzgerald
Director
-$1.4M Sep 15, 2026

Owned after: shares held right after the person's latest buy or sale, from the Form 4 the date links to. % of shares: that holding over the shares outstanding on the latest cover page. Only people who bought or sold in this period are listed, and options, restricted units and shares held by others are not counted, so the rows are not a total of what insiders own.

Trade by trade, newest first

Every trade · each date links to its Form 4

Of 52 open-market sales by officers and directors, 5 came in the 30 days before a 10-Q, a 10-K or a results 8-K. Dates only, from the filing index; most companies close the window for insider trades in the weeks before results, so a trade there is often under a 10b5-1 plan.

DateInsiderTypeSharesValue
Nov 11, 2026 Richard Pulik Sale -45,195 1.9M
Nov 11, 2026 Richard Pulik Sale -82,170 3.5M
Nov 11, 2026 Richard Pulik Sale -47,635 2.0M
Nov 10, 2026 Eric Venker Sale (10b5-1) -158,194 6.4M
Nov 10, 2026 Eric Venker Sale (10b5-1) -29,749 1.2M
Nov 10, 2026 Richard Pulik Sale -125,000 5.2M
Nov 3, 2026 Eric Venker Sale (10b5-1) -200,000 7.3M
Oct 28, 2026 Eric Venker Sale (10b5-1) -200,000 7.3M
Oct 20, 2026 Eric Venker Sale (10b5-1) -185,856 6.5M
Oct 20, 2026 Eric Venker Sale (10b5-1) -14,144 501K
Oct 1, 2026 Melissa B. Epperly Sale (10b5-1) -16,850 608K
Oct 1, 2026 Melissa B. Epperly Sale (10b5-1) -900 33K
Sep 30, 2026 Eric Venker Sale (10b5-1) -200,000 7.3M
Sep 15, 2026 Meghan Fitzgerald Sale (10b5-1) -4,712 187K
Sep 15, 2026 Meghan Fitzgerald Sale (10b5-1) -400 16K
Sep 15, 2026 Melissa B. Epperly Sale (10b5-1) -4,338 172K
Sep 15, 2026 Melissa B. Epperly Sale (10b5-1) -600 24K
Sep 8, 2026 Meghan Fitzgerald Sale (10b5-1) -20,000 798K
Aug 28, 2026 Eric Venker Sale (10b5-1) -166,182 5.9M
Aug 28, 2026 Eric Venker Sale (10b5-1) -33,818 1.2M
Aug 21, 2026 Mayukh Sukhatme Sale -144,756 5.3M
Aug 20, 2026 Mayukh Sukhatme Sale -17,519 653K
Aug 19, 2026 Mayukh Sukhatme Sale -172,899 6.4M
Aug 18, 2026 Mayukh Sukhatme Sale -105,141 3.8M
Aug 18, 2026 Mayukh Sukhatme Sale -31,801 1.2M
Aug 17, 2026 Mayukh Sukhatme Sale -284,707 10.3M
Aug 14, 2026 Mayukh Sukhatme Sale -243,177 8.8M
Jul 27, 2026 Eric Venker Sale (10b5-1) -200,000 7.0M
Jun 30, 2026 QVT Financial LP (indirect) Sale -12,380 437K
Jun 30, 2026 Daniel Allen Gold (indirect) Sale -12,380 437K
Jun 30, 2026 Keith S. Manchester (indirect) Sale -12,380 437K
Jun 30, 2026 Keith S. Manchester Sale -200,000 7.1M
Jun 30, 2026 Meghan Fitzgerald Sale (10b5-1) -10,000 349K
Jun 29, 2026 QVT Financial LP (indirect) Sale -200,000 6.9M
Jun 29, 2026 QVT Financial LP (indirect) Sale -600,000 20.8M
Jun 29, 2026 Daniel Allen Gold (indirect) Sale -200,000 6.9M
Jun 29, 2026 Daniel Allen Gold (indirect) Sale -600,000 20.8M
Jun 29, 2026 Keith S. Manchester (indirect) Sale -200,000 6.9M
Jun 29, 2026 Keith S. Manchester (indirect) Sale -600,000 20.8M
Jun 29, 2026 Melissa B. Epperly Sale (10b5-1) -15,002 515K
Jun 29, 2026 Melissa B. Epperly Sale (10b5-1) -2,748 95K
Jun 26, 2026 QVT Financial LP (indirect) Sale -300,783 10.2M
Jun 26, 2026 QVT Financial LP (indirect) Sale -325,000 11.1M
Jun 26, 2026 Daniel Allen Gold (indirect) Sale -300,783 10.2M
Jun 26, 2026 Daniel Allen Gold (indirect) Sale -325,000 11.1M
Jun 26, 2026 Keith S. Manchester (indirect) Sale -300,783 10.2M
Jun 26, 2026 Keith S. Manchester (indirect) Sale -325,000 11.1M
Jun 26, 2026 Mayukh Sukhatme Sale -500,000 17.0M
Jun 25, 2026 Mayukh Sukhatme Sale -500,000 17.1M
Jun 24, 2026 Eric Venker Sale (10b5-1) -153,766 5.1M
Jun 24, 2026 Eric Venker Sale (10b5-1) -46,234 1.5M
May 22, 2026 Eric Venker Sale (10b5-1) -200,000 6.1M
Show the other 37 trades

Sources

Form 4s from SEC's filing index. An insider files one within two business days of a trade.

Also

Insider selling plans: the 10b5-1 plans and Form 144 notices behind planned sales.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/ROIV/export.csv") into a cell.

Next:Insider selling plans
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.